Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal

被引:16
作者
Ghadirian, P. [1 ]
Robidoux, A. [2 ]
Nassif, E. [3 ]
Martin, G. [3 ]
Potvin, C. [3 ]
Patocskai, E. [3 ]
Younan, R. [3 ]
Larouche, N. [3 ]
Venne, A. [1 ]
Zhang, S. [4 ]
Royer, R. [4 ]
Narod, S. A. [4 ]
机构
[1] Ctr Hosp Univ Montreal CRCHUM Hotel Dieu, Epidemiol Res Unit, Montreal, PQ, Canada
[2] Univ Montreal, Dept Surg, Scotia Chair Breast Canc Diag & Treatment, Breast Canc Ctr,CHUM, Montreal, PQ, Canada
[3] Univ Montreal Hosp, Dept Surg, Hotel Dieu Montreal, Montreal, PQ, Canada
[4] Womens Coll Hosp Res Inst, Familial Breast Canc Res, Toronto, ON, Canada
关键词
BRCA1; BRCA2; breast cancer; DCIS; French-Canadian; prevalence; FOUNDER MUTATIONS; HIGH-RISK; PREVALENCE; WOMEN; FAMILIES;
D O I
10.1111/cge.12174
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Study subjects were French-Canadian women with ductal carcinoma in situ (DCIS) or invasive breast cancer (incident or prevalent) who were treated and followed at a single breast cancer clinic affiliated with the Research Center of University of Montreal (CRCHUM), who were either aged less than 50years at diagnosis or who were 50years or older and with at least two affected first- or second-degree relatives. Subjects were tested for six founder mutations (three in BRCA1 and three in BRCA2); 1093 eligible cases were tested. Of these, 56 women (5.1%) were mutation carriers, including 43 BRCA2 carriers and 13 BRCA1 carriers. The prevalence of mutations was 5.3% for unselected women aged 50 and less and was 4.6% for familial cases over age 50. The prevalence of mutations was 3.3% for women with DCIS and was 5.3% for women with invasive cancer. It is rational to offer genetic testing to all French-Canadian women diagnosed recently or in the past with either DCIS or invasive breast cancer before age 50 or with familial breast cancer above age 50.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 16 条
[1]  
[Anonymous], 2011, CAN CANC STAT 2011
[2]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[3]   Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer [J].
Cavallone, Luca ;
Arcand, Suzanna L. ;
Maugard, Christine M. ;
Nolet, Serge ;
Gaboury, Louis A. ;
Mes-Masson, Anne-Marie ;
Ghadirian, Parviz ;
Provencher, Diane ;
Tonin, Patricia N. .
FAMILIAL CANCER, 2010, 9 (04) :507-517
[4]   A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas [J].
Donenberg, Talia ;
Lunn, John ;
Curling, DuVaughn ;
Turnquest, Theodore ;
Krill-Jackson, Elisa ;
Royer, Robert ;
Narod, Steven A. ;
Hurley, Judith .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) :591-596
[5]   The contribution of founder mutations to early-onset breast cancer in French-Canadian women [J].
Ghadirian, P. ;
Robidoux, A. ;
Zhang, P. ;
Royer, R. ;
Akbari, M. ;
Zhang, S. ;
Fafard, E. ;
Costa, M. ;
Martin, G. ;
Potvin, C. ;
Patocskai, E. ;
Larouche, N. ;
Younan, R. ;
Nassif, E. ;
Giroux, S. ;
Narod, S. A. ;
Rousseau, F. ;
Foulkes, W. D. .
CLINICAL GENETICS, 2009, 76 (05) :421-426
[6]   A high proportion of founder BRCA1 mutations in Polish breast cancer families [J].
Górski, B ;
Jakubowska, A ;
Huzarski, T ;
Byrski, T ;
Gronwald, J ;
Grzybowska, E ;
Mackiewicz, A ;
Stawicka, M ;
Bebenek, M ;
Sorokin, D ;
Fiszer-Maliszewska, L ;
Haus, O ;
Janiszewska, H ;
Niepsuj, S ;
Gózdz, S ;
Zaremba, L ;
Posmyk, M ;
Pluzanska, M ;
Kilar, E ;
Czudowska, D ;
Wasko, B ;
Miturski, R ;
Kowalczyk, JR ;
Urbanski, K ;
Szwiec, M ;
Koc, J ;
Debniak, B ;
Rozmiarek, A ;
Debniak, T ;
Cybulski, C ;
Kowalska, E ;
Toloczko-Grabarek, A ;
Zajaczek, S ;
Menkiszak, J ;
Medrek, K ;
Masojc, B ;
Mierzejewski, M ;
Narod, SA ;
Lubinski, J .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) :683-686
[7]   Prevalence of BRCA1 and BRCA2 Mutations in Women with Breast Carcinoma In Situ and Referred for Genetic Testing [J].
Hall, Michael J. ;
Reid, Julia E. ;
Wenstrup, Richard J. .
CANCER PREVENTION RESEARCH, 2010, 3 (12) :1579-1585
[8]   Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet Syndrome [J].
Kwong, Anna Ka-Yee ;
Fung, Cheuk-Wing ;
Chan, Siu-Yuen ;
Wong, Virginia Chun-Nei .
PLOS ONE, 2012, 7 (07)
[9]   The risk of breast cancer in women with a BRCA1 mutation from North America and Poland [J].
Lubinski, Jan ;
Huzarski, Tomasz ;
Byrski, Tomasz ;
Lynch, Henry T. ;
Cybulski, Cezary ;
Ghadirian, Parviz ;
Stawicka, Malgorzata ;
Foulkes, William D. ;
Kilar, Ewa ;
Kim-Sing, Charmaine ;
Neuhausen, Susan L. ;
Armel, Susan ;
Gilchrist, Dawna ;
Sweet, Kevin ;
Gronwald, Jacek ;
Eisen, Andrea ;
Gorski, Bohdan ;
Sun, Ping ;
Narod, Steven A. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (01) :229-234
[10]   Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years [J].
Malone, Kathleen E. ;
Daling, Janet R. ;
Doody, David R. ;
Hsu, Li ;
Bernstein, Leslie ;
Coates, Ralph J. ;
Marchbanks, Polly A. ;
Simon, Michael S. ;
McDonald, Jill A. ;
Norman, Sandra A. ;
Strom, Brian L. ;
Burkman, Ronald T. ;
Ursin, Giske ;
Deapen, Dennis ;
Weiss, Linda K. ;
Folger, Suzanne ;
Madeoy, Jennifer J. ;
Friedrichsen, Danielle M. ;
Suter, Nicola M. ;
Humphrey, Mariela C. ;
Spirtas, Robert ;
Ostrander, Elaine A. .
CANCER RESEARCH, 2006, 66 (16) :8297-8308